A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03761849|
Recruitment Status : Completed
First Posted : December 3, 2018
Last Update Posted : September 22, 2022
Information provided by (Responsible Party):
- Study Details
- Tabular View
- Results Submitted
- How to Read a Study Record
Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the ClinicalTrials.gov Results Quality Control (QC) review process. Results information is submitted to ClinicalTrials.gov by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||March 17, 2022|
|Actual Study Completion Date :||March 17, 2022|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
March 16, 2023 ||April 11, 2023 Submission with QC Comments|
May 4, 2023 ||June 2, 2023 Submission with QC Comments|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Rodrigues FB, Ferreira JJ, Wild EJ. Huntington's Disease Clinical Trials Corner: June 2019. J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.